Nashua, NH-September 4, 2014-iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that, in addition to Volpara®Density™ volumetric breast density assessment software, Volpara®Analytics™ and Volpara®Dose™ solutions are now available as part of iCAD's PowerLook Advanced Mammography Platform (AMP)®. With the addition of these quantitative breast imaging tools, radiologists will be able to evaluate the performance of all major digital mammography and tomosynthesis units and obtain patient-specific dose information to make informed treatment decisions in real time.
"Today's healthcare environment is increasingly data-driven and our customers require up-to-the-minute access to analytics that impact patient care," said Ken Ferry, CEO of iCAD. "By incorporating additional breast imaging analytic and reporting solutions from Volpara, our PowerLook AMP customers will be able to go beyond automated mammography unit settings and mine patient-specific, real-time information for actionable insights regarding care delivery within their practices and across patient populations."
PowerLook AMP is a next-generation digital mammography computer-aided detection (CAD) platform that provides radiologists with the ability to customize their 2D CAD solution to meet the needs of their individual work environment. Now with the option to incorporate VolparaAnalytics and VolparaDose in addition to VolparaDensity, PowerLook AMP users will, among other benefits, be able to:
Improve patient safety and reporting through personalized measurements of density, patient dose, breast compression and other volumetric factors designed to help maintain accuracy and consistent quality in breast screening.
Optimize performance/utilization of staff and mammography systems.
Utilize a globally-accepted algorithm incorporating breast density to generate patient-specific radiation dose estimates, which can be automatically entered in patient communications.
"The PowerLook AMP platform has gained a well-established user base and is now considered a key clinical decision support technology in thousands of mammography suites," said Ralph Highnam, PhD, CEO of Volpara Solutions. "The addition of Volpara's dose and analytics tools to the suite is a natural fit that will only enhance the value of this technology to customers. We are proud to continue our collaboration with iCAD to help address the specialized diagnostic needs of the radiology practice."
